ArticleFrontiers in immunology2025

Adverse pro-tumorigenic effects of IDO1 catalytic inhibitors mediated by the non-enzymatic function of IDO1 in tumor cells.

Sofia Rossini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.